Gene expression patterns associated with p53 status in breast cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Breast cancer subtypes exhibit distinct genetic defects, with p53 mutations more prevalent in aggressive subtypes.
• Prognostic effects of p53 are challenging to isolate due to its link with other clinical factors.
• Combining primary tumor data with isogenic cell lines aids in studying p53's role across subtypes.

Purpose of the Study:

• To identify p53-dependent gene expression signatures in breast cancer cell lines.
• To compare these signatures with p53 mutation-associated genes in primary tumors.
• To establish a biologically relevant gene signature for p53 loss that is independent of breast cancer subtype.

Main Methods:

• Utilized p53-RNAi to generate gene expression profiles in four breast cancer cell lines.
• Assessed p53 responses under both non-induced and doxorubicin-induced conditions.
• Compared cell line signatures with tumor-derived gene sets and validated prognostic value.

Main Results:

• Identified distinct yet common p53-dependent gene expression patterns across cell lines, reflecting basal vs. luminal differences.
• Discovered a conserved gene signature for p53 loss, overlapping with tumor data and excluding subtype-specific genes not downstream of p53.
• Validated this signature's ability to predict relapse-free, disease-specific, and overall survival in independent datasets.

Conclusions:

• Experimental and biologically refined methods yield prognostic and relevant gene lists for p53 status in heterogeneous breast cancer.
• A refined gene signature for p53 loss, independent of subtype, was identified and validated.
• This approach enhances understanding of p53's role and provides a potential prognostic biomarker across breast cancer subtypes.